2-(4-Chlorophenyl)-N-methylacetamide

Catalog No.: 
ACTQRA587
CAS No.: 
60336-41-6
Molecular Formula: 
C9H10ClNO
Molecular Weight: 
183.64
2-(4-Chlorophenyl)-N-methylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$175.00InquiryInquiry
5g95%$561.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Chlorophenyl)-N-methylacetamide
IUPAC Name2-(4-chlorophenyl)-N-methylacetamide
MDL No.MFCD02309765
Molecular FormulaC9H10ClNO
Molecular Weight183.64
SMILESO=C(NC)CC1=CC=C(Cl)C=C1
InChI KeyLTADIWWYTXOETE-UHFFFAOYSA-N
Synonym2-(4-Chlorophenyl)-N-Methylacetamide;Benzeneacetamide, 4-chloro-N-methyl-
CAS No.60336-41-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTQRA587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDKIY807 route compound structure diagram
    ACDKIY8071878-66-6In Stock
  4. Then
  5. ACTQRA587 route product structure diagram
    ACTQRA58760336-41-6
Inquiry

2. ACTQRA587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXRAB374 route compound structure diagram
    ACXRAB37452449-43-1In Stock
  4. Then
  5. ACTQRA587 route product structure diagram
    ACTQRA58760336-41-6
Inquiry

3. ACTQRA587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTQRA587 route product structure diagram
    ACTQRA58760336-41-6
Inquiry

Comments (0)